MYND.AI INC (MYND)

US6289881079 - ADR

1.8801  +0.15 (+8.68%)

After market: 1.8701 -0.01 (-0.53%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to MYND. MYND was compared to 67 industry peers in the Diversified Consumer Services industry. MYND has a bad profitability rating. Also its financial health evaluation is rather negative. MYND is valied quite expensively at the moment, while it does show a decent growth rate.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MYND has reported negative net income.
In the past 5 years MYND reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: MYND reported negative operating cash flow in multiple years.

1.2 Ratios

MYND has a Return On Assets of -11.69%. This is in the lower half of the industry: MYND underperforms 65.15% of its industry peers.
MYND has a Return On Equity of -49.14%. This is in the lower half of the industry: MYND underperforms 68.18% of its industry peers.
Industry RankSector Rank
ROA -11.69%
ROE -49.14%
ROIC N/A
ROA(3y)-19.42%
ROA(5y)-14.26%
ROE(3y)-63.65%
ROE(5y)-50.69%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 24.94%, MYND is doing worse than 81.82% of the companies in the same industry.
In the last couple of years the Gross Margin of MYND has grown nicely.
MYND does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y8.8%

More info and screens

1

2. Health

2.1 Basic Checks

MYND does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MYND has more shares outstanding
MYND has more shares outstanding than it did 5 years ago.
The debt/assets ratio for MYND is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -0.27, we must say that MYND is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of MYND (-0.27) is worse than 68.18% of its industry peers.
A Debt/Equity ratio of 0.81 indicates that MYND is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.81, MYND is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Altman-Z -0.27
ROIC/WACCN/A
WACC8.07%

2.3 Liquidity

MYND has a Current Ratio of 1.22. This is a normal value and indicates that MYND is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.22, MYND is in line with its industry, outperforming 43.94% of the companies in the same industry.
MYND has a Quick Ratio of 1.22. This is a bad value and indicates that MYND is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 1.00, MYND is not doing good in the industry: 60.61% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 88.14% over the past year.
Looking at the last year, MYND shows a very strong growth in Revenue. The Revenue has grown by 727.13%.
MYND shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.45% yearly.
EPS 1Y (TTM)88.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-192.22%
Revenue 1Y (TTM)727.13%
Revenue growth 3Y113.66%
Revenue growth 5Y21.45%
Sales Q2Q%-25.4%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MYND. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MYND!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MYND.AI INC

NYSEARCA:MYND (12/20/2024, 8:26:23 PM)

After market: 1.8701 -0.01 (-0.53%)

1.8801

+0.15 (+8.68%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)09-06 2024-09-06
Earnings (Next)N/A N/A
Inst Owners8.78%
Inst Owner Change-90.26%
Ins OwnersN/A
Ins Owner Change0%
Market Cap85.82M
Analysts40
Price TargetN/A
Short Float %0.03%
Short Ratio0.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.21
P/FCF N/A
P/OCF N/A
P/B 1.11
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.87
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS9.06
BVpS1.69
TBVpS-0.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.69%
ROE -49.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.94%
FCFM N/A
ROA(3y)-19.42%
ROA(5y)-14.26%
ROE(3y)-63.65%
ROE(5y)-50.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y8.8%
F-ScoreN/A
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 1
Altman-Z -0.27
F-ScoreN/A
WACC8.07%
ROIC/WACCN/A
Cap/Depr(3y)72.54%
Cap/Depr(5y)72.03%
Cap/Sales(3y)7.61%
Cap/Sales(5y)7.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-192.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)727.13%
Revenue growth 3Y113.66%
Revenue growth 5Y21.45%
Sales Q2Q%-25.4%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-19.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-224.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-217.1%
OCF growth 3YN/A
OCF growth 5YN/A